Science-advisor
REGISTER info/FAQ
Login
username
password
     
forgot password?
register here
 
Research articles
  search articles
  reviews guidelines
  reviews
  articles index
My Pages
my alerts
  my messages
  my reviews
  my favorites
 
 
Stat
Members: 3643
Articles: 2'488'730
Articles rated: 2609

29 March 2024
 
  » pubmed » pmid17676035

 Article overview


LKB1 modulates lung cancer differentiation and metastasis
Hongbin Ji ; Matthew R Ramsey ; D Neil Hayes ; Cheng Fan ; Kate McNamara ; Piotr Kozlowski ; Chad Torrice ; Michael C Wu ; Takeshi Shimamura ; Samanthi A Perera ; Mei-Chih Liang ; Dongpo Cai ; George N Naumov ; Lei Bao ; Cristina M Contreras ; Danan Li ; Liang Chen ; Janakiraman Krishnamurthy ; Jussi Koivunen ; Lucian R Chirieac ; Robert F Padera ; Roderick T Bronson ; Neal I Lindeman ; David C Christiani ; Xihong Lin ; Geoffrey I Shapiro ; Pasi A Jänne ; Bruce E Johnson ; Matthew Meyerson ; David J Kwiatkowski ; Diego H Castrillon ; Nabeel Bardeesy ; Norman E Sharpless ; Kwok-Kin Wong ;
Date 16 Aug 2007
Journal Nature, 448 (7155), 807-10
AbstractGermline mutation in serine/threonine kinase 11 (STK11, also called LKB1) results in Peutz-Jeghers syndrome, characterized by intestinal hamartomas and increased incidence of epithelial cancers. Although uncommon in most sporadic cancers, inactivating somatic mutations of LKB1 have been reported in primary human lung adenocarcinomas and derivative cell lines. Here we used a somatically activatable mutant Kras-driven model of mouse lung cancer to compare the role of Lkb1 to other tumour suppressors in lung cancer. Although Kras mutation cooperated with loss of p53 or Ink4a/Arf (also known as Cdkn2a) in this system, the strongest cooperation was seen with homozygous inactivation of Lkb1. Lkb1-deficient tumours demonstrated shorter latency, an expanded histological spectrum (adeno-, squamous and large-cell carcinoma) and more frequent metastasis compared to tumours lacking p53 or Ink4a/Arf. Pulmonary tumorigenesis was also accelerated by hemizygous inactivation of Lkb1. Consistent with these findings, inactivation of LKB1 was found in 34% and 19% of 144 analysed human lung adenocarcinomas and squamous cell carcinomas, respectively. Expression profiling in human lung cancer cell lines and mouse lung tumours identified a variety of metastasis-promoting genes, such as NEDD9, VEGFC and CD24, as targets of LKB1 repression in lung cancer. These studies establish LKB1 as a critical barrier to pulmonary tumorigenesis, controlling initiation, differentiation and metastasis.
Source PubMed, pmid17676035 doi: 10.1038/nature06030
Services Forum | Review | Favorites   
 
Visitor rating: did you like this article? no 1   2   3   4   5   yes

No review found.
 Did you like this article?

This article or document is ...
important:
of broad interest:
readable:
new:
correct:
Global appreciation:

  Note: answers to reviews or questions about the article must be posted in the forum section.
Authors are not allowed to review their own article. They can use the forum section.

browser claudebot






ScienXe.org
» my Online CV
» Free


News, job offers and information for researchers and scientists:
home  |  contact  |  terms of use  |  sitemap
Copyright © 2005-2024 - Scimetrica